Local Therapy with Continued EGFR Tyrosine Kinase Inhibitor Therapy as a Treatment Strategy in EGFR-Mutant Advanced Lung Cancers That Have Developed Acquired Resistance to EGFR Tyrosine Kinase Inhibitors

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Journal of Thoracic Oncology

Topics

Medicine

Cancer Oncology

Internal Medicine

Pulmonary And Respiratory Medicine

Combination Therapy

Show all topics

DOI

10.1097/jto.0b013e31827e1f83

License

publisher-specific-oa